α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke
Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infect...
Saved in:
| Published in | International journal of chronic obstructive pulmonary disease Vol. 11; no. Issue 1; pp. 1279 - 1286 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
New Zealand
Dove Medical Press Ltd
01.06.2016
Dove Medical Press |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1178-2005 1176-9106 1178-2005 |
| DOI | 10.2147/COPD.S105717 |
Cover
| Abstract | Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air-liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×10(4) 50% Tissue Culture Infective Dose [TCID50]/transwell) infection for 24 hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-λ1, OAS1, and MX1. When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection. |
|---|---|
| AbstractList | Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air-liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×10(4) 50% Tissue Culture Infective Dose [TCID50]/transwell) infection for 24 hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-λ1, OAS1, and MX1. When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection.Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air-liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×10(4) 50% Tissue Culture Infective Dose [TCID50]/transwell) infection for 24 hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-λ1, OAS1, and MX1. When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection. Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air–liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×10 4 50% Tissue Culture Infective Dose [TCID 50 ]/transwell) infection for 24 hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-λ1, OAS1 , and MX1 . When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection. Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air-liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×10(4) 50% Tissue Culture Infective Dose [TCID50]/transwell) infection for 24 hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-λ1, OAS1, and MX1. When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection. Reena Berman, Di Jiang, Qun Wu, Hong Wei Chu Department of Medicine, National Jewish Health, Denver, CO, USA Abstract: Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air-liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×104 50% Tissue Culture Infective Dose [TCID50]/transwell) infection for 24hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-λ1, OAS1, and MX1. When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection. Keywords: α1-antitrypsin, rhinovirus, COPD, cigarette smoke, ICAM-1 Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection. We determined whether α1-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells. Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air–liquid interface to induce mucociliary differentiation. These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5×104 50% Tissue Culture Infective Dose [TCID50]/transwell) infection for 24 hours. WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genesinterferon-λ1, OAS1, and MX1. When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold. HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT. A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation. Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection. |
| Author | Jiang, Di Wu, Qun Berman, Reena Chu, Hong Wei |
| AuthorAffiliation | Department of Medicine, National Jewish Health, Denver, CO, USA |
| AuthorAffiliation_xml | – name: Department of Medicine, National Jewish Health, Denver, CO, USA |
| Author_xml | – sequence: 1 givenname: Reena surname: Berman fullname: Berman, Reena – sequence: 2 givenname: Di surname: Jiang fullname: Jiang, Di – sequence: 3 givenname: Qun surname: Wu fullname: Wu, Qun – sequence: 4 givenname: Hong Wei surname: Chu fullname: Chu, Hong Wei |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27354786$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkstuEzEUhkeoiF5gxxpZYtMFKT72zNjZIFWhQKVKRQLWlmOfSRwm9mB7SvNYvAjPhENC1Vas_Mv-_J_rcXXgg8eqegn0jEEt3s6uP78_-wK0ESCeVEcAQk4Ypc3BPX1YHae0KqIVAp5Vh0zwphayPaqG379gcu6zy3EzJOdJRDsaTCQunQ83Lo6JON-hyS74osgQ3VrHDVmOa-2JdvGn3hAcXF5i73RPDPZ9Ing7hISW5ECMW-iIOSNJ6_Adn1dPO90nfLE_T6pvHy6-zj5Nrq4_Xs7OryamZpAnqCUXdUcpp1IbsE0tQVqccyY77DrZwryTvBaNpFraqa1bwYFKxq1gwsyBn1SXO18b9Erts1ZBO_X3IsSF0jE706NiIIUtIeZSNnULRhtmDdMNsw3Txtri9W7nNYzzNVqDPkfdPzB9-OLdUi3CjaqnQFuoi8Hp3iCGHyOmrNYubTulPYYxKZCUCtrwKS_o60foKozRl1Yp1hZsykFuq3t1P6O7VP4NtgBvdoCJIaWI3R0CVG33Rm33Ru33puDsEW5c1tuZl3pc__9PfwAtScfm |
| CitedBy_id | crossref_primary_10_3892_mmr_2025_13472 crossref_primary_10_3390_microorganisms12122526 crossref_primary_10_3388_jspaci_35_248 crossref_primary_10_1016_j_ijid_2017_10_002 crossref_primary_10_1042_CS20180337 crossref_primary_10_1002_rmv_2157 crossref_primary_10_3390_biomedicines11020516 crossref_primary_10_1097_ALN_0000000000003727 crossref_primary_10_3389_fcimb_2020_00277 crossref_primary_10_1371_journal_pone_0291948 crossref_primary_10_1371_journal_pone_0163927 crossref_primary_10_1186_s12931_023_02511_5 crossref_primary_10_3390_medicina57040397 crossref_primary_10_2217_imt_2018_0047 crossref_primary_10_1016_j_antiviral_2018_06_007 crossref_primary_10_5799_jmid_537178 |
| ContentType | Journal Article |
| Copyright | 2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Berman et al. This work is published and licensed by Dove Medical Press Limited 2016 |
| Copyright_xml | – notice: 2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Berman et al. This work is published and licensed by Dove Medical Press Limited 2016 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.2147/COPD.S105717 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1178-2005 |
| EndPage | 1286 |
| ExternalDocumentID | oai_doaj_org_article_2187d1d5b885461cac2dc2a52d52acdd PMC4910614 27354786 10_2147_COPD_S105717 |
| Genre | Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL122321 – fundername: NIAID NIH HHS grantid: R01 AI106287 |
| GroupedDBID | --- 0YH 29J 2WC 53G 5GY 5VS 7RV 7X7 88E 8C1 8FI 8FJ AAYXX ABUWG ADBBV ADRAZ AENEX AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR C1A CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PSQYO RNS RPM TDBHL TR2 UKHRP VDV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c421t-ea8374f00308ac1d54818deb328feff861bf8347580a8d9d467310823d727cb13 |
| IEDL.DBID | M48 |
| ISSN | 1178-2005 1176-9106 |
| IngestDate | Wed Aug 27 01:24:36 EDT 2025 Thu Aug 21 18:15:58 EDT 2025 Thu Sep 04 23:47:48 EDT 2025 Fri Jul 25 10:12:38 EDT 2025 Thu Jan 02 22:24:49 EST 2025 Tue Jul 01 03:09:31 EDT 2025 Thu Apr 24 23:03:15 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Issue 1 |
| Keywords | ICAM-1 α1-antitrypsin cigarette smoke rhinovirus COPD |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/3.0 The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c421t-ea8374f00308ac1d54818deb328feff861bf8347580a8d9d467310823d727cb13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/COPD.S105717 |
| PMID | 27354786 |
| PQID | 2680093181 |
| PQPubID | 5500198 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2187d1d5b885461cac2dc2a52d52acdd pubmedcentral_primary_oai_pubmedcentral_nih_gov_4910614 proquest_miscellaneous_1800705393 proquest_journals_2680093181 pubmed_primary_27354786 crossref_primary_10_2147_COPD_S105717 crossref_citationtrail_10_2147_COPD_S105717 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-06 |
| PublicationDateYYYYMMDD | 2016-06-01 |
| PublicationDate_xml | – month: 06 year: 2016 text: 2016-06 |
| PublicationDecade | 2010 |
| PublicationPlace | New Zealand |
| PublicationPlace_xml | – name: New Zealand – name: London |
| PublicationTitle | International journal of chronic obstructive pulmonary disease |
| PublicationTitleAlternate | Int J Chron Obstruct Pulmon Dis |
| PublicationYear | 2016 |
| Publisher | Dove Medical Press Ltd Dove Medical Press |
| Publisher_xml | – name: Dove Medical Press Ltd – name: Dove Medical Press |
| References | 12740257 - Chest. 2003 May;123(5):1425-34 24689994 - Respirology. 2014 May;19(4):508-13 22180562 - Innate Immun. 2012 Aug;18(4):617-26 21166595 - J Interferon Cytokine Res. 2011 Jan;31(1):79-87 22542099 - Curr Opin Virol. 2012 Jun;2(3):287-93 20224072 - Am J Respir Cell Mol Biol. 2011 Jan;44(1):118-26 24209388 - Respir Res. 2013 Nov 09;14:122 12551926 - J Biol Chem. 2003 Apr 4;278(14):11954-61 24111585 - Am J Respir Cell Mol Biol. 2014 Mar;50(3):471-82 25630941 - J Allergy Clin Immunol. 2015 Jul;136(1):177-188.e11 11149899 - FASEB J. 2001 Jan;15(1):115-122 20716026 - Expert Opin Emerg Drugs. 2010 Dec;15(4):685-94 11502863 - Lab Invest. 2001 Aug;81(8):1119-31 23226468 - PLoS One. 2012;7(11):e51078 24876172 - Eur Respir J. 2014 Jul;44(1):169-77 20470412 - BMC Pulm Med. 2010 May 14;10:30 15466377 - Am J Pathol. 2004 Oct;165(4):1097-106 23862647 - COPD. 2013 Dec;10(6):687-95 25771504 - Curr Opin Virol. 2015 Jun;12 :38-46 25658455 - PLoS One. 2015 Feb 06;10(2):e0117330 22536580 - Can Respir J. 2012 Mar-Apr;19(2):109-16 25111775 - Toxicol In Vitro. 2014 Dec;28(8):1430-5 25341065 - Am J Respir Crit Care Med. 2014 Dec 1;190(11):1229-42 19840959 - Eur Respir J. 2010 Jun;35(6):1256-63 21199162 - Respirology. 2011 Apr;16(3):508-16 25727857 - Respir Med. 2015 Apr;109(4):490-9 22808255 - PLoS One. 2012;7(7):e40762 20375160 - J Virol. 2010 Aug;84(15):7418-26 21147646 - Eur J Med Res. 2010 Nov 4;15 Suppl 2:164-74 21816185 - Virus Res. 2011 Sep;160(1-2):360-6 24130483 - PLoS Pathog. 2013;9(10):e1003664 23988199 - Respir Res. 2013 Aug 30;14:88 12368227 - FASEB J. 2002 Dec;16(14):1934-6 17395890 - Am J Respir Cell Mol Biol. 2007 Aug;37(2):144-51 17050563 - Eur Respir J. 2007 Feb;29(2):240-50 21226542 - Curr Med Res Opin. 2011 Mar;27(3):579-88 24074582 - Virology. 2013 Nov;446(1-2):199-206 24627537 - Eur Respir J. 2014 Jul;44(1):87-96 19175599 - Allergy. 2009 Mar;64(3):375-86 11083705 - Chest. 2000 Nov;118(5):1480-5 24365768 - J Heart Lung Transplant. 2014 Mar;33(3):309-15 |
| References_xml | – reference: 24074582 - Virology. 2013 Nov;446(1-2):199-206 – reference: 11149899 - FASEB J. 2001 Jan;15(1):115-122 – reference: 24876172 - Eur Respir J. 2014 Jul;44(1):169-77 – reference: 20716026 - Expert Opin Emerg Drugs. 2010 Dec;15(4):685-94 – reference: 24130483 - PLoS Pathog. 2013;9(10):e1003664 – reference: 23988199 - Respir Res. 2013 Aug 30;14:88 – reference: 22542099 - Curr Opin Virol. 2012 Jun;2(3):287-93 – reference: 25771504 - Curr Opin Virol. 2015 Jun;12 :38-46 – reference: 12368227 - FASEB J. 2002 Dec;16(14):1934-6 – reference: 17050563 - Eur Respir J. 2007 Feb;29(2):240-50 – reference: 21147646 - Eur J Med Res. 2010 Nov 4;15 Suppl 2:164-74 – reference: 25341065 - Am J Respir Crit Care Med. 2014 Dec 1;190(11):1229-42 – reference: 20224072 - Am J Respir Cell Mol Biol. 2011 Jan;44(1):118-26 – reference: 11083705 - Chest. 2000 Nov;118(5):1480-5 – reference: 12740257 - Chest. 2003 May;123(5):1425-34 – reference: 23862647 - COPD. 2013 Dec;10(6):687-95 – reference: 11502863 - Lab Invest. 2001 Aug;81(8):1119-31 – reference: 20375160 - J Virol. 2010 Aug;84(15):7418-26 – reference: 22808255 - PLoS One. 2012;7(7):e40762 – reference: 22536580 - Can Respir J. 2012 Mar-Apr;19(2):109-16 – reference: 25111775 - Toxicol In Vitro. 2014 Dec;28(8):1430-5 – reference: 25658455 - PLoS One. 2015 Feb 06;10(2):e0117330 – reference: 22180562 - Innate Immun. 2012 Aug;18(4):617-26 – reference: 24689994 - Respirology. 2014 May;19(4):508-13 – reference: 24111585 - Am J Respir Cell Mol Biol. 2014 Mar;50(3):471-82 – reference: 23226468 - PLoS One. 2012;7(11):e51078 – reference: 24627537 - Eur Respir J. 2014 Jul;44(1):87-96 – reference: 21816185 - Virus Res. 2011 Sep;160(1-2):360-6 – reference: 20470412 - BMC Pulm Med. 2010 May 14;10:30 – reference: 21166595 - J Interferon Cytokine Res. 2011 Jan;31(1):79-87 – reference: 25727857 - Respir Med. 2015 Apr;109(4):490-9 – reference: 21199162 - Respirology. 2011 Apr;16(3):508-16 – reference: 15466377 - Am J Pathol. 2004 Oct;165(4):1097-106 – reference: 21226542 - Curr Med Res Opin. 2011 Mar;27(3):579-88 – reference: 24365768 - J Heart Lung Transplant. 2014 Mar;33(3):309-15 – reference: 12551926 - J Biol Chem. 2003 Apr 4;278(14):11954-61 – reference: 25630941 - J Allergy Clin Immunol. 2015 Jul;136(1):177-188.e11 – reference: 19840959 - Eur Respir J. 2010 Jun;35(6):1256-63 – reference: 24209388 - Respir Res. 2013 Nov 09;14:122 – reference: 19175599 - Allergy. 2009 Mar;64(3):375-86 – reference: 17395890 - Am J Respir Cell Mol Biol. 2007 Aug;37(2):144-51 |
| SSID | ssj0056771 |
| Score | 2.1572573 |
| Snippet | Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD. Cigarette smoke (CS) increases the... Reena Berman, Di Jiang, Qun Wu, Hong Wei Chu Department of Medicine, National Jewish Health, Denver, CO, USA Abstract: Human rhinovirus (HRV) infections target... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1279 |
| SubjectTerms | Aged alpha 1-Antitrypsin - pharmacology alpha1-antitrypsin Antiviral Agents - pharmacology Bronchi - drug effects Bronchi - enzymology Bronchi - pathology Bronchi - virology Case-Control Studies Cell culture Cells, Cultured cigarette smoke Cigarettes COPD Epithelial Cells - drug effects Epithelial Cells - enzymology Epithelial Cells - pathology Epithelial Cells - virology Female Gene expression Genetic engineering HIV Host-Pathogen Interactions Human immunodeficiency virus Human subjects Humans ICAM-1 Infections Intercellular Adhesion Molecule-1 - genetics Intercellular Adhesion Molecule-1 - metabolism Male Middle Aged Original Research Picornaviridae Infections - enzymology Picornaviridae Infections - pathology Picornaviridae Infections - prevention & control Picornaviridae Infections - virology Polymerase chain reaction Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - enzymology Pulmonary Disease, Chronic Obstructive - pathology Respiratory Mucosa - drug effects Respiratory Mucosa - enzymology Respiratory Mucosa - pathology Respiratory Mucosa - virology Respiratory Tract Infections - enzymology Respiratory Tract Infections - pathology Respiratory Tract Infections - prevention & control Respiratory Tract Infections - virology rhinovirus Rhinovirus - drug effects Rhinovirus - pathogenicity Smoke - adverse effects Smoking Smoking - adverse effects Statistical analysis Viral infections Viral Load |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwELVQF4gN4k2gICPBCkVN7DhxlqVQVUgFJKjUneX4oUa0SZTkAv0sfoRvYsbOvfQiEBt2UWxFtmc8c8YZnyHkuQUU4nwj0txpkRbe8xScIE8rxzwXVQUIF28jH78rj06Kt6fi9EqpL8wJi_TAceH2wAVVNreikVIUZW60YdYwLZgVTBtr0fpmdbYOpqINFmUVQ628CnogYso71uTZM_0AhgnL24YiZb-cUeDs_xPQ_D1f8ooDOrxFbi7Ike7HEd8m11x3h1w_Xv6N3yXDj-95uo-3bsfLYWo7OiIrq5voeNZ2_Zd2XE10nXrVwRMdItEEDWX6qG7Hr_qSugEvaZyDVlI805-o-zb0k7N07qlpQ03c2dHpov_s7pGTwzefDo7SpZ5CagqWz6nTEI0WPlDUaANrWoC3thBNM-md97LMGy95ARFEpqWtLdhQAH-ScQsgxzQ5v092ur5zDwm13ta-auA7yM7jbaMtE0y6ssmM0zxLyMv1wiqzkI1jzYtzBUEHikEdvP_wWn2MYkjIi03vZe5_6fcKZbTpg9TY4QUojFoURv1LYRKyu5awWvbrpFgp8WwH4E5Cnm2aYafhUuvO9atJ5RK5kQSveUIeRIXYjARAIBKjlQmptlRla6jbLV17Fti8izpE5Y_-x9wekxsA6MqYyrZLduZx5Z4AaJqbp2F__AS2URf_ priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bbtQwELWgSIiXijuBgowETyh07cSO9wmVhapCKiBBpb5Fji80oiRpkgX6WfwI38SM492yCHiLEidyMjP2GWd8DiFPLKAQ5yuRMqdFmnufpTAJZmnhuM9EUQDCxd3Ih2_lwVH-5lgcxwW3IZZVrsbEMFDb1uAa-S6XCrNvmJBedGcpqkbh39UooXGZXGEwBmNgqsW6xEPIYkq4WCEhqGdyKnxHZZ7dxbv3r55_QJHbIFV2MSUF5v6_wc0_qyZ_m4b2r5PtiB_p3mTwG-SSa26Sq4fxD_kt0v38wdI93Hvbn3dD3dAeuVndQPuTumm_1v1yoKsCrAaOaDfRTdAg1kd13X_T59R1uFXjFHyT4sr-QN33rh2cpWNLTR2UcUdHhy_tZ3ebHO2__rg4SKOqQmpyzsbUachJcx-IarRhFlIWpizk1Fx5572SrPIqyyGPmGll5xZGUoCAimcWoI6pWHaHbDVt4-4Rar2d-6KC5yBHj7eVtlxw5WQ1M05ns4Q8W33Y0kTKcVS-OC0h9UAzlGiGMpohIU_XreO7_6PdS7TRug0SZIcTbf-pjPEGd6nCwstVSolcMqMNt4Zrwa3g2libkJ2VhcsYtUN54WMJeby-DPGGn1o3rl0OJVPIkCSyeZaQu5NDrHsCUBDp0WRCig1X2ejq5pWmPgmc3vk85Ob3_9-tB-QaADY5lartkK2xX7qHAIrG6lHw_F-zsw3j priority: 102 providerName: ProQuest |
| Title | α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27354786 https://www.proquest.com/docview/2680093181 https://www.proquest.com/docview/1800705393 https://pubmed.ncbi.nlm.nih.gov/PMC4910614 https://doaj.org/article/2187d1d5b885461cac2dc2a52d52acdd |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD7aRUK8IO5kjMpI8IQyaiex3QeEtrJpQuqYgEp9i5zY3iJKkiUtrD-LP8Jv4jiXisJ44aWKGjtKfM6Jv885_g7AC40oxNgk8qlRkR9aG_g4CQa-MMwGkRCIcN1u5MkZP52G72fRbAv6aqPdANY3UjtXT2pazQ-ur1ZvMeDfuDRmGorX4w_n7w4-uYK1VGzDLs5J3NGwSbj-nhBx0VIvKjiG95C3KfB_9XbSwCJwEld8Y55q5PxvwqB_plL-Njed3IU7Hagkh60X3IMtk9-HW5Pus_kDKH_-oP6h25Bbrco6y0nlBFtNTarLLC--ZdWyJn1WVo5HpGw1KEhTwY-orPquVsSUbv_GHB2WuOX-mpjrsqiNJouCpFlTLndhSP21-GIewvTk-PP41O9KLfhpyOjCNwqJamgb9RqVUo08hkqNRJtJa6yVnCZWBiGSi6GSeqTx9Yq4ULJAI_5JExo8gp28yM0TINrqkRUJXscJ91idKM0iJg1PhqlRwdCDV_3AxmmnQ-7KYcxj5CPOIrGzSNxZxIOX69bds_-j3ZGz0bqNU81u_iiqi7gLQuwlhcaHS6SMQk5TlTKdMhUxHTGVau3Bfm_huPfEmHHpln0QCXnwfH0ag9ANtcpNsaxjKp1sUhSMAg8etw6xvpPeoTwQG66ycaubZ_LsshH6DkcNYd_7755P4TYCPN6mtu3DzqJammcIohbJALbFTOCvHNMB7B4dn51_HDQLEoMmcn4Bc-AiAQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2ggJHoCYVu7MTxHhAqW6ot7RYkWqm31PGDRpQkJLuU_VNI_BF-EzN5bFkE3HpbbZzI8by-icfzEfLMAAqxLo38wKrID53jPgRB7seWOR7FMSBcPI082Rfjw_DtUXS0Qr73Z2GwrLL3iY2jNoXGb-QbTEjMviEgvSq_-MgahburPYVGqxa7dn4GKVv9cmcL5LvO2Pabg9HY71gFfB2yYOpbBTlZ6JpGLUoHBiB7IA3klEw665wUQeokDwFHD5Q0QwOeBCCQZNxAqNdpwOG5l8jlkHOBViRHi5KSSMRtghfEApzIQLSF9sgEtDF6937rxQck1W2o0c5DYMMU8Dd4-2eV5m9hb_sGud7hVbrZKthNsmLzW-TKpNuRv03Knz8CfxPP-lbzss5yWmEvWFvT6iTLi69ZNatpX_CVwy9atu0taEMOSFVWnak5tSUeDTkFW6C4k1BT-60samvotKA6a5h4p5bWn4tP9g45vJD1vktW8yK39wk1zgxdnMJzsCeQM6kyLGLSinSgreIDjzzvFzbRXYtzZNo4TSDVQTEkKIakE4NH1heju3f_x7jXKKPFGGzI3fxRVB-Tzr7hLhkbeLlUyigUgVaaGc1UxEzElDbGI2u9hJPOS9TJuU575OniMtg3LrXKbTGrk0BiR6aID7lH7rUKsZgJQE9sxyY8Ei-pytJUl6_k2UnTQzwcNt8CHvx_Wk_I1fHBZC_Z29nffUiuAVgUbZncGlmdVjP7CADZNH3cWAElxxdtdr8Atr1JiA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9NAFH4qRaq4IHYMBQaJnpBJPN4mB4RKQtRSWipBpd7MeBZqUWxjJ5T8LK78CH4T73lJCQJuvVn22JqZt33P8xaAJxpRiLFp6HpGhm5gre-iEfTd2HDrh3GMCJeykfcPop2j4PVxeLwGP_pcGAqr7HVio6h1oegf-YBHgrxvNEgD24VFHE6mL8ovLnWQopPWvp1GyyJ7ZnGG7lv9fHeCtN7ifPrq_XjH7ToMuCrg3sw1Ev2zwDZFW6TyNMJ3T2j0L7mwxloReakVfoCYeiiFHmnUKgiHBPc1mn2Vej5-9xJcjn1cE2Wpj5fhJWEUt86eF0eoUIZRG3RPXYEG47eHk2fvqMFu0ybt3Bw2XQP-BnX_jNj8zQROr8HVDruy7ZbZrsOayW_Axn53On8Typ_fPXeb8n6rRVlnOauoLqypWXWS5cXXrJrXrA_-yvGKlW2pC9Y0CmQyq87kgpmS0kROUS4YnSrUzHwri9poNiuYypquvDPD6s_FJ3MLji5kv2_Del7k5i4wbfXIxil-h-oDWZ1KzUMuTJQOlZH-0IGn_cYmqit3Tl03ThN0e4gMCZEh6cjgwNZydLf2f4x7STRajqHi3M2NovqYdLKOb4lY4-JSIcIg8pRUXCsuQ65DLpXWDmz2FE46jVEn5_ztwOPlY5R12mqZm2JeJ56g6kyhP_IduNMyxHImCEOpNFvkQLzCKitTXX2SZydNPfFg1PwXuPf_aT2CDRS45M3uwd59uIK4MWoj5jZhfVbNzQPEZrP0YSMEDD5ctNT9AvAwTb4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%B11-Antitrypsin+reduces+rhinovirus+infection+in+primary+human+airway+epithelial+cells+exposed+to+cigarette+smoke&rft.jtitle=International+journal+of+chronic+obstructive+pulmonary+disease&rft.au=Berman%2C+Reena&rft.au=Jiang%2C+Di&rft.au=Wu%2C+Qun&rft.au=Chu%2C+Hong+Wei&rft.date=2016-06-01&rft.pub=Dove+Medical+Press&rft.issn=1176-9106&rft.eissn=1178-2005&rft.volume=11&rft.spage=1279&rft.epage=1286&rft_id=info:doi/10.2147%2FCOPD.S105717&rft_id=info%3Apmid%2F27354786&rft.externalDocID=PMC4910614 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-2005&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-2005&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-2005&client=summon |